BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 284168)

  • 1. Treatment of Pediatric Acute Lymphoblastic Leukemia: A Historical Perspective.
    Hayashi H; Makimoto A; Yuza Y
    Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitoxantrone as a substitute for daunorubicin during induction in newly diagnosed lymphoblastic leukemia and lymphoma.
    Nickel RS; Keller F; Bergsagel J; Cooper T; Daves M; Sabnis H; Lew G
    Pediatr Blood Cancer; 2014 May; 61(5):810-4. PubMed ID: 24357218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial and harmful effects of anthracyclines in the treatment of childhood acute lymphoblastic leukaemia: a systematic review and meta-analysis.
    Childhood Acute Lymphoblastic Leukaemia Collaborative Group (CALLCG)
    Br J Haematol; 2009 May; 145(3):376-88. PubMed ID: 19236609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current management of childhood acute lymphocytic leukemia.
    Ekert H
    Indian J Pediatr; 1981; 48(393):491-9. PubMed ID: 7035349
    [No Abstract]   [Full Text] [Related]  

  • 5. Childhood acute lymphocytic leukemia: progress and problems in treatment.
    Bowman WP
    Can Med Assoc J; 1981 Jan; 124(2):129-42. PubMed ID: 7006781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The definitive treatment of children with acute leukemia.
    Walters TR
    Med Clin North Am; 1976 Sep; 60(5):987-1000. PubMed ID: 781418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adriamycin in combination chemotherapy of adult acute lymphoblastic leukemia: a Southwest Oncology Group study.
    Shaw MT; Raab SO
    Med Pediatr Oncol; 1977; 3(3):261-6. PubMed ID: 284167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of induction anthracycline on long-term failure-free survival in childhood acute lymphoblastic leukemia.
    Hitchcock-Bryan S; Gelber R; Cassady JR; Sallan SE
    Med Pediatr Oncol; 1986; 14(4):211-5. PubMed ID: 3462467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult acute leukaemia.
    Atkinson K; Wells DG; Clink HM; Kay HE; Powles R; McElwain TJ
    Br J Cancer; 1974 Sep; 30(3):272-8. PubMed ID: 4141625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vincristine and prednisone vs vincristine, L-asparaginase, and prednisone for second remission induction of acute lymphocytic leukemia in children.
    Herson J; Starling KA; Dyment PG; Humphrey GB; Pullen J; Vats T
    Med Pediatr Oncol; 1979; 6(4):317-23. PubMed ID: 384187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remission induction with daunomycin, vincristine, and prednisone in adult acute lymphocytic leukemia.
    Einhorn LH; Bond WH
    Oncology; 1977; 34(1):25-8. PubMed ID: 266674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and cytokinetic aspects of remission induction of childhood acute lymphoblastic leukemia (ALL): addition of an anthracycline to vincristine and prednisone.
    Sallan SE; Camitta BM; Frei E; Furman L; Leavitt P; Bishop Y; Jaffe N
    Med Pediatr Oncol; 1977; 3(3):281-7. PubMed ID: 284168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current aspects of the treatment of acute leukemia].
    Alekseev GA
    Klin Med (Mosk); 1973 Dec; 51(12):5-9. PubMed ID: 4591758
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.